James Hamilton
Net worth: 18 M $ as of 2026-05-30
Net worth: 18 M $ as of 2026-05-30
James C.
Hamilton is the founder of NanoValent Pharmaceuticals, Inc. Dr. Hamilton is Chief Medical Officer, Head-Research & Development at Arrowhead Pharmaceuticals, Inc. since 2025.
Formerly, Dr. Hamilton was Chief Executive Officer at Calando Pharmaceuticals, Inc. Dr. Hamilton completed undergraduate studies at Miami University and earned an MBA and a doctorate from The Ohio State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-04 | 236,958 ( 0.17% ) | 18 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2025-01-31 |
| Companies | Position | End |
|---|---|---|
NanoValent Pharmaceuticals, Inc.
NanoValent Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures proprietary targeted nanoparticle drugs | Founder | - |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | President | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics | Health Technology |
Miami University
Miami University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NanoValent Pharmaceuticals, Inc.
NanoValent Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and manufactures proprietary targeted nanoparticle drugs | Health Technology |
Select your edition
All financial news and data tailored to specific country editions